Schonfeld Strategic Advisors’s Cymabay Therapeutics CBAY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-244,620	Closed	-$3.65M	–	2344
2023 Q3	$3.65M	Buy	244,620 +173,938	+246%	+$2.31M	0.03%	639
2023 Q2	$774K	Buy	+70,682	New	+$658K	0.01%	1066
2023 Q1	–	Sell	-121,683	Closed	-$763K	–	2826
2022 Q4	$763K	Buy	+121,683	New	+$462K	0.01%	1297
2021 Q3	–	Sell	-15,003	Closed	-$65K	–	2596
2021 Q2	$65K	Buy	+15,003	New	+$66.5K	﹤0.01%	1861
2020 Q4	–	Sell	-501,368	Closed	-$3.63M	–	1957
2020 Q3	$3.63M	Buy	501,368 +420,986	+524%	+$2.25M	0.07%	366
2020 Q2	$281K	Buy	80,382 +24,132	+43%	+$69.6K	0.01%	1016
2020 Q1	$83K	Buy	+56,250	New	+$94.4K	0.01%	1022
2019 Q4	–	Sell	-77,800	Closed	-$398K	–	1539
2019 Q3	$398K	Sell	77,800 -494,400	-86%	-$2.99M	0.01%	709
2019 Q2	$4.1M	Buy	572,200 +268,800	+89%	+$3.04M	0.14%	172
2019 Q1	$4.03M	Buy	303,400 +281,200	+1,267%	+$2.99M	0.14%	194
2018 Q4	$175K	Buy	22,200 +8,200	+59%	+$78K	0.01%	962
2018 Q3	$156K	Sell	14,000 -12,000	-46%	-$149K	0.01%	765
2018 Q2	$349K	Buy	+26,000	New	+$325K	0.02%	605
2017 Q4	–	Sell	-34,410	Closed	-$278K	–	925
2017 Q3	$278K	Buy	+34,410	New	+$233K	0.03%	468